The ResApp (ASX:RAP) share price is soaring 10% today. Here's why.

The ResApp Health Ltd (ASX: RAP) share price has soared today after a positive announcement on a new partnership deal.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ResApp Health Ltd (ASX: RAP) share price has surged today following a positive announcement on a partnership agreement.

At the time of writing, shares in the digital health company are 10% higher at 11 cents. This compares to the All Ordinaries Index (ASX: XAO) which is flat at 6,399 points.

New partnership

ResApp advised it has signed a 12-month marketing agreement with Australia's largest consumer healthcare network, HealthEngine. The new partnership will see HealthEngine integrate its booking network into ResApp's mobile medical application, SleepCheck.

The easy to use, direct-to-consumer mobile application assesses a person's risk of obstructive sleep apnoea by analysing breathing and snoring. It requires no accessories or hardware other than the user's smartphone to make an assessment.

If SleepCheck identifies a person is at risk of obstructive sleep apnoea, the application will direct them to see a doctor. HealthEngine's integration helps patients find and connect with healthcare service providers through a dedicated landing page.

Under the agreement, ResApp will retain all revenues generated from the app download. In addition, for every new patient referred through the Sleep Check application, ResApp will received a portion of the revenue.

Both companies did not state any forecasted earnings as the partnership is in its early stages. However, ResApp was confident of a significant consumer uptake in SleepCheck, unlocking a new revenue stream.

The new partnership has the flexibility to be extended beyond the 12-month agreement.

What did management say?

ResApp CEO and managing director Tony Keating welcomed the collaboration, saying:

This partnership is a tremendous achievement for ResApp and highlights SleepCheck's potential in the Australian market. The agreement with HealthEngine provides us with access to a trusted and reliable consumer healthcare network, which will further improve our offering by allowing users to immediately progress the treatment journey.

This agreement is further evidence of ResApp's ability to attract large, industry leading partners that it can leverage to drive growth well into the future. The company has a number of partnerships pending, which will provide it with a solid foundation to scale.

ResApp share price summary

Despite the uplift in its share price today, ResApp shares have been on a downhill trend for a rolling 52 weeks. Reaching a low of 5.5 cents in March, the ResApp share price has somewhat recovered, up 100%. But the numbers are still a long way off its share price high of 41.5 cents achieved this time last year.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Animation of a man measuring a percentage sign, symbolising rising interest rates.
Share Market News

Here's when Westpac says the RBA will now cut interest rates

Will borrowers need to wait until the middle of next year for relief? Let's find out.

Read more »

Boys making faces and flexing.
Opinions

3 ASX 300 shares to buy and hold for the long run

I believe these stocks have loads of growth potential.

Read more »

Young girl drinking milk showing off muscles.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a great end to the trading week for ASX investors today.

Read more »

Hands reaching high for a trophy with a sunset in the background.
Record Highs

The ASX 200 Index is on its way to another all-time high today. Here's why

These blue chip stocks are driving the index towards a new record today...

Read more »

Group of friends trading stocks on their phones. symbolising the 3 most traded ASX 200 shares today
Share Market News

3 ASX mining stocks topping the most-traded list in October

Chinese stimulus news and company announcements likely contributed to the higher trading activity.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Share Gainers

3 ASX 200 stocks smashing the benchmark this week

These three ASX 200 stocks are leading the charge this week. Here’s how.

Read more »

Two people tired and resting after sports race.
Broker Notes

Fundie rates 2 ASX 200 stocks in short-term pain but with long-term gain potential

Blackwattle Investment Partners sees these 2 ASX 200 stocks as worthy of a buy and hold strategy.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why A2 Milk, EOS, GQG, and Mineral Resources shares are racing higher today

These shares are ending the week strongly. But why?

Read more »